This technical note brings the first version of the Thematic Budget for Science, Technology and Innovation in Medicines (OTMED ST&I), which aims to investigate federal government spending in this area. This is a new methodology, which is yet to mature, but which aims to contribute data on this strategic public spending – especially in the context of Covid-19 – and essential to guarantee the right to health and access to medicines.